126 related articles for article (PubMed ID: 37461816)
1. Pharmacological targeting of Axin2 suppresses cell growth and metastasis in colorectal cancer.
Cheng LZ; Huang DL; Tang ZR; Zhang JH; Xiong T; Zhou C; Zhang NX; Fu R; Cheng YX; Wu ZQ
Br J Pharmacol; 2023 Dec; 180(23):3071-3091. PubMed ID: 37461816
[TBL] [Abstract][Full Text] [Related]
2. Esculetin suppresses tumor growth and metastasis by targeting Axin2/E-cadherin axis in colorectal cancer.
Kim WK; Byun WS; Chung HJ; Oh J; Park HJ; Choi JS; Lee SK
Biochem Pharmacol; 2018 Jun; 152():71-83. PubMed ID: 29534875
[TBL] [Abstract][Full Text] [Related]
3. An AXIN2 Mutant Allele Associated With Predisposition to Colorectal Neoplasia Has Context-Dependent Effects on AXIN2 Protein Function.
Mazzoni SM; Petty EM; Stoffel EM; Fearon ER
Neoplasia; 2015 May; 17(5):463-72. PubMed ID: 26025668
[TBL] [Abstract][Full Text] [Related]
4. TRAF6 inhibits colorectal cancer metastasis through regulating selective autophagic CTNNB1/β-catenin degradation and is targeted for GSK3B/GSK3β-mediated phosphorylation and degradation.
Wu H; Lu XX; Wang JR; Yang TY; Li XM; He XS; Li Y; Ye WL; Wu Y; Gan WJ; Guo PD; Li JM
Autophagy; 2019 Sep; 15(9):1506-1522. PubMed ID: 30806153
[TBL] [Abstract][Full Text] [Related]
5. Regulation of APC and AXIN2 expression by intestinal tumor suppressor CDX2 in colon cancer cells.
Olsen AK; Coskun M; Bzorek M; Kristensen MH; Danielsen ET; Jørgensen S; Olsen J; Engel U; Holck S; Troelsen JT
Carcinogenesis; 2013 Jun; 34(6):1361-9. PubMed ID: 23393221
[TBL] [Abstract][Full Text] [Related]
6. Kinase GSK3β functions as a suppressor in colorectal carcinoma through the FTO-mediated MZF1/c-Myc axis.
Zhang Z; Gao Q; Wang S
J Cell Mol Med; 2021 Mar; 25(5):2655-2665. PubMed ID: 33533172
[TBL] [Abstract][Full Text] [Related]
7. p53 regulates nuclear GSK-3 levels through miR-34-mediated Axin2 suppression in colorectal cancer cells.
Kim NH; Cha YH; Kang SE; Lee Y; Lee I; Cha SY; Ryu JK; Na JM; Park C; Yoon HG; Park GJ; Yook JI; Kim HS
Cell Cycle; 2013 May; 12(10):1578-87. PubMed ID: 23624843
[TBL] [Abstract][Full Text] [Related]
8. Canonical Wnt suppressor, Axin2, promotes colon carcinoma oncogenic activity.
Wu ZQ; Brabletz T; Fearon E; Willis AL; Hu CY; Li XY; Weiss SJ
Proc Natl Acad Sci U S A; 2012 Jul; 109(28):11312-7. PubMed ID: 22745173
[TBL] [Abstract][Full Text] [Related]
9. RNF6 promotes colorectal cancer invasion and migration via the Wnt/β-catenin pathway by inhibiting GSK3β activity.
Li Q; Wang G; Tao J; Chen W
Pathol Res Pract; 2021 Sep; 225():153545. PubMed ID: 34352441
[TBL] [Abstract][Full Text] [Related]
10. [Mechanism of Wnt signaling pathway regulation by a truncated mutant of Axin2 in colorectal cancer].
Wang FW; Wen L; Zhu SW; Yao Q; Cai YM; Ma G
Ai Zheng; 2007 Oct; 26(10):1041-6. PubMed ID: 17927870
[TBL] [Abstract][Full Text] [Related]
11. CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/β-catenin signaling via transactivation of GSK-3β and Axin2 expression.
Yu J; Liu D; Sun X; Yang K; Yao J; Cheng C; Wang C; Zheng J
Cell Death Dis; 2019 Jan; 10(1):26. PubMed ID: 30631044
[TBL] [Abstract][Full Text] [Related]
12. Gamma-mangostin isolated from garcinia mangostana suppresses colon carcinogenesis and stemness by downregulating the GSK3β/β-catenin/CDK6 cancer stem pathway.
Wu AT; Yeh YC; Huang YJ; Mokgautsi N; Lawal B; Huang TH
Phytomedicine; 2022 Jan; 95():153797. PubMed ID: 34802869
[TBL] [Abstract][Full Text] [Related]
13. GSK-3β phosphorylation-dependent degradation of ZNF281 by β-TrCP2 suppresses colorectal cancer progression.
Zhu Y; Zhou Q; Zhu G; Xing Y; Li S; Ren N; Liu T; Zhu A; Bai Y; Piao D
Oncotarget; 2017 Oct; 8(51):88599-88612. PubMed ID: 29179460
[TBL] [Abstract][Full Text] [Related]
14. Structural Basis of the Interaction between Human Axin2 and SIAH1 in the Wnt/β-Catenin Signaling Pathway.
Chen L; Liu YP; Tian LF; Li M; Yang S; Wang S; Xu W; Yan XX
Biomolecules; 2023 Apr; 13(4):. PubMed ID: 37189394
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-induced lncRNA STEAP3-AS1 activates Wnt/β-catenin signaling to promote colorectal cancer progression by preventing m
Zhou L; Jiang J; Huang Z; Jin P; Peng L; Luo M; Zhang Z; Chen Y; Xie N; Gao W; Nice EC; Li JQ; Chen HN; Huang C
Mol Cancer; 2022 Aug; 21(1):168. PubMed ID: 35986274
[TBL] [Abstract][Full Text] [Related]
16. Nerigoside suppresses colorectal cancer cell growth and metastatic potential through inhibition of ERK/GSK3β/β-catenin signaling pathway.
Wen SY; Chen YY; Deng CM; Zhang CQ; Jiang MM
Phytomedicine; 2019 Apr; 57():352-363. PubMed ID: 30831484
[TBL] [Abstract][Full Text] [Related]
17. ALKBH5 Drives Immune Suppression Via Targeting AXIN2 to Promote Colorectal Cancer and Is a Target for Boosting Immunotherapy.
Zhai J; Chen H; Wong CC; Peng Y; Gou H; Zhang J; Pan Y; Chen D; Lin Y; Wang S; Kang W; To KF; Chen Z; Nie Y; He HH; Sung JJ; Yu J
Gastroenterology; 2023 Aug; 165(2):445-462. PubMed ID: 37169182
[TBL] [Abstract][Full Text] [Related]
18. miR-103/107 prolong Wnt/β-catenin signaling and colorectal cancer stemness by targeting Axin2.
Chen HY; Lang YD; Lin HN; Liu YR; Liao CC; Nana AW; Yen Y; Chen RH
Sci Rep; 2019 Jul; 9(1):9687. PubMed ID: 31273221
[TBL] [Abstract][Full Text] [Related]
19. The antibiotic drug trimethoprim suppresses tumour growth and metastasis via targeting Snail.
Ren BX; Li Y; Li HM; Lu T; Wu ZQ; Fu R
Br J Pharmacol; 2022 Jun; 179(11):2659-2677. PubMed ID: 34855201
[TBL] [Abstract][Full Text] [Related]
20. Nuclear AXIN2 represses MYC gene expression.
Rennoll SA; Konsavage WM; Yochum GS
Biochem Biophys Res Commun; 2014 Jan; 443(1):217-22. PubMed ID: 24299953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
